表紙:馬用サプリメント製品の世界市場:サプリメント別- 業界分析、規模、シェア、成長、動向、予測(2022年~2031年)
市場調査レポート
商品コード
1140656

馬用サプリメント製品の世界市場:サプリメント別- 業界分析、規模、シェア、成長、動向、予測(2022年~2031年)

Equine Supplement Products Market (Supplement: Proteins/Amino Acids, Vitamins, Enzymes, Electrolytes/Minerals & Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

出版日: | 発行: Transparency Market Research | ページ情報: 英文 187 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
馬用サプリメント製品の世界市場:サプリメント別- 業界分析、規模、シェア、成長、動向、予測(2022年~2031年)
出版日: 2022年08月12日
発行: Transparency Market Research
ページ情報: 英文 187 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の馬用サプリメント製品市場について調査分析し、市場動向、セグメント分析、地域分析、企業プロファイルなどを提供しています。

目次

第1章 序文

第2章 前提と調査手法

第3章 エグゼクティブサマリー:世界の馬用サプリメント製品市場

第4章 市場の概要

  • イントロダクション
    • 定義
    • 業界の進化/発展
  • 概要
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • 世界の馬用サプリメント製品市場の分析と予測(2017年~2031年)
  • ポーターのファイブフォース分析

第5章 市場の見通し

  • 新製品の発売
  • 主な合併と買収
  • 馬頭数の概要:地域別
  • 規制シナリオ:地域別/世界

第6章 世界の馬用サプリメント製品市場の分析と予測:サプリメント別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額の予測:サプリメント別(2017年~2031年)
    • タンパク質・アミノ酸
    • ビタミン
    • 酵素
    • 電解質・ミネラル
    • その他
  • 市場魅力分析:サプリメント別

第7章 世界の馬用サプリメント製品市場の分析と予測:用途別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額の予測:用途別(2017年~2031年)
    • パフォーマンスの向上/回復
    • 関節障害の予防
    • その他
  • 市場魅力分析:用途別

第8章 世界の馬用サプリメント製品市場の分析と予測:流通チャネル別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額の予測:流通チャネル別(2017年~2031年)
    • 動物病院薬局
    • 小売薬局
    • その他
  • 市場魅力分析:流通チャネル別

第9章 世界の馬用サプリメント製品市場の分析と予測:地域別

  • 主な調査結果
  • 市場金額の予測:地域別
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場魅力分析:地域別

第10章 北米の馬用サプリメント製品市場の分析と予測

  • イントロダクション
    • 主な調査結果
  • 市場金額の予測:サプリメント別(2017年~2031年)
  • 市場金額の予測:用途別(2017年~2031年)
  • 市場金額の予測:流通チャネル別(2017年~2031年)
  • 市場金額の予測:国別(2017年~2031年)
    • 米国
    • カナダ
  • 市場魅力分析

第11章 欧州の馬用サプリメント製品市場の分析と予測

第12章 アジア太平洋の馬用サプリメント製品市場の分析と予測

第13章 ラテンアメリカの馬用サプリメント製品市場の分析と予測

第14章 中東・アフリカの馬用サプリメント製品市場の分析と予測

第15章 競合情勢

  • 市場企業 - 競合マトリックス:階層・企業規模別
  • 市場シェア分析:企業別(2018年)
  • 企業プロファイル
    • Zoetis
    • Boehringer Ingelheim International GmbH
    • Bayer AG
    • Purina Animal Nutrition LLC.
    • Vetoquinol SA
    • Kentucky Equine Research
    • Plusvital Limited
    • Lallemand Inc.
    • Virbac
図表

List of Tables

  • Table 01: Global Equine Supplement Products Market Size (US$ Mn) Forecast, by Supplement, 2017-2031
  • Table 02: Global Equine Supplement Products Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 03: Global Equine Supplement Products Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 04: Global Equine Supplement Products Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 05: North America Equine Supplement Products Market Value (US$ Mn) Forecast, by Supplement, 2017-2031
  • Table 06: North America Equine Supplement Products Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 07: North America Equine Supplement Products Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 08: North America Equine Supplement Products Market Size (US$ Mn) Forecast, by Country, 2017-2031
  • Table 09: Europe Equine Supplement Products Market Value (US$ Mn) Forecast, by Supplement, 2017-2031
  • Table 10: Europe Equine Supplement Products Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 11: Europe Equine Supplement Products Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 12: Europe Equine Supplement Products Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 13: Asia Pacific Equine Supplement Products Market Value (US$ Mn) Forecast, by Supplement, 2017-2031
  • Table 14: Asia Pacific Equine Supplement Products Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 15: Asia Pacific Equine Supplement Products Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 16: Asia Pacific Equine Supplement Products Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 17: Latin America Equine Supplement Products Market Value (US$ Mn) Forecast, by Supplement, 2017-2031
  • Table 18: Latin America Equine Supplement Products Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 19: Latin America Equine Supplement Products Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 20: Latin America Equine Supplement Products Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 21: Middle East & Africa Equine Supplement Products Market Value (US$ Mn) Forecast, by Supplement, 2017-2031
  • Table 22: Middle East & Africa Equine Supplement Products Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 23: Middle East & Africa Equine Supplement Products Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 24: Middle East & Africa Equine Supplement Products Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

List of Figures

  • Figure 01: Global Equine Supplement Products Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 02: Global Equine Supplement Products Market Value Share, by Supplement, 2018
  • Figure 03: Global Equine Supplement Products Market Value Share, by Application, 2018
  • Figure 04: Global Equine Supplement Products Market Value Share, by Distribution Channel, 2018
  • Figure 05: Global Equine Supplement Products Market Value Share, by Region, 2018
  • Figure 06: Global Equine Supplement Products Market Value Share Analysis, by Supplement, 2021 and 2031
  • Figure 07: Global Equine Supplement Products Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Protein/Amino Acid, 2017-2031
  • Figure 08: Global Equine Supplement Products Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Vitamins, 2017-2031
  • Figure 09: Global Equine Supplement Products Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Enzymes, 2017-2031
  • Figure 10: Global Equine Supplement Products Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Electrolytes & Minerals, 2017-2031
  • Figure 11: Global Equine Supplement Products Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2017-2031
  • Figure 12: Global Equine Supplement Products Market Attractiveness Analysis, by Supplement, 2022-2031
  • Figure 13: Global Equine Supplement Products Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 14: Global Equine Supplement Products Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Performance Enhancement& Recovery, 2017-2031
  • Figure 15: Global Equine Supplement Products Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Joint Disorder Prevention, 2017-2031
  • Figure 16: Global Equine Supplement Products Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2017-2031
  • Figure 17: Global Equine Supplement Products Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 18: Global Equine Supplement Products Market Value Share Analysis, by Distribution Channel, 2021 and 2031
  • Figure 19: Global Equine Supplement Products Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Veterinary Hospital Pharmacies, 2017-2031
  • Figure 20: Global Equine Supplement Products Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Retail Pharmacies, 2017-2031
  • Figure 21: Global Equine Supplement Products Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2017-2031
  • Figure 22: Global Equine Supplement Products Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 23: Global Equine Supplement Products Market Value Share (%), by Region, 2021 and 2031
  • Figure 24: Global Equine Supplement Products Market Attractiveness Analysis, by Region, 2022-2031
  • Figure 25: North America Equine Supplement Products Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 26: North America Equine Supplement Products Market Value Share Analysis, by Supplement, 2021 and 2031
  • Figure 27: North America Equine Supplement Products Market Attractiveness Analysis, by Supplement, 2022-2031
  • Figure 28: North America Equine Supplement Products Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 29: North America Equine Supplement Products Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 30: North America Equine Supplement Products Market Value Share Analysis, by Distribution Channel, 2021 and 2031
  • Figure 31: North America Equine Supplement Products Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 32: North America Equine Supplement Products Market Value Share Analysis, by Country, 2021 and 2031
  • Figure 33: North America Equine Supplement Products Market Attractiveness Analysis, by Country, 2022-2031
  • Figure 34: Europe Equine Supplement Products Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 35: Europe Equine Supplement Products Market Value Share Analysis, by Supplement, 2021 and 2031
  • Figure 36: Europe Equine Supplement Products Market Attractiveness Analysis, by Supplement, 2022-2031
  • Figure 37: Europe Equine Supplement Products Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 38: Europe Equine Supplement Products Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 39: Europe Equine Supplement Products Market Value Share Analysis, by Distribution Channel, 2021 and 2031
  • Figure 40: Europe Equine Supplement Products Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 41: Europe Equine Supplement Products Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 42: Europe Equine Supplement Products Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 43: Asia Pacific Equine Supplement Products Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 44: Asia Pacific Equine Supplement Products Market Value Share Analysis, by Supplement, 2021 and 2031
  • Figure 45: Asia Pacific Equine Supplement Products Market Attractiveness Analysis, by Supplement, 2022-2031
  • Figure 46: Asia Pacific Equine Supplement Products Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 47: Asia Pacific Equine Supplement Products Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 48: Asia Pacific Equine Supplement Products Market Value Share Analysis, by Distribution Channel, 2021 and 2031
  • Figure 49: Asia Pacific Equine Supplement Products Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 50: Asia Pacific Equine Supplement Products Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 51: Asia Pacific Equine Supplement Products Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 52: Latin America Equine Supplement Products Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 53: Latin America Equine Supplement Products Market Value Share Analysis, by Supplement, 2021 and 2031
  • Figure 54: Latin America Equine Supplement Products Market Attractiveness Analysis, by Supplement, 2022-2031
  • Figure 55: Latin America Equine Supplement Products Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 56: Latin America Equine Supplement Products Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 57: Latin America Equine Supplement Products Market Value Share Analysis, by Distribution Channel, 2021 and 2031
  • Figure 58: Latin America Equine Supplement Products Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 59: Latin America Equine Supplement Products Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 60: Latin America Equine Supplement Products Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 61: Middle East & Africa Equine Supplement Products Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 62: Middle East & Africa Equine Supplement Products Market Value Share Analysis, by Supplement, 2021 and 2031
  • Figure 63: Middle East & Africa Equine Supplement Products Market Attractiveness Analysis, by Supplement, 2022-2031
  • Figure 64: Middle East & Africa Equine Supplement Products Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 65: Middle East & Africa Equine Supplement Products Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 66: Middle East & Africa Equine Supplement Products Market Value Share Analysis, by Distribution Channel, 2021 and 2031
  • Figure 67: Middle East & Africa Equine Supplement Products Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 68: Middle East & Africa Equine Supplement Products Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 69: Middle East & Africa Equine Supplement Products Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 70: Boehringer Ingelheim International GmbH Animal Health Business Revenue (US$ Mn) and Y-o-Y Growth (%), 2016-2018
  • Figure 71: Boehringer Ingelheim International GmbH R&D expenditure (US$ Mn) and Y-o-Y Growth (%), 2018
  • Figure 72: Boehringer Ingelheim International GmbH Breakdown of Net Sales, by Product Segment, 2018
  • Figure 73: Boehringer Ingelheim International GmbH Breakdown of Net Sales, by Region, 2018
  • Figure 74: Bayer AG Animal Health Revenue (US$ Mn) and Y-o-Y Growth (%), 2016-2018
  • Figure 75: Bayer AG R&D Expenses and Marketing & Sales Expenses (US$ Mn), 2017-2018
  • Figure 76: Bayer AG Breakdown of Net Sales, by Business Segment, 2018
  • Figure 77: Bayer AG Breakdown of Animal Health Segment Net Sales, by Region, 2018
  • Figure 78: Zoetis Revenue (US$ Mn) and Y-o-Y Growth (%), 2016-2018
  • Figure 79: Zoetis R&D expenditure (US$ Mn) and Y-o-Y Growth (%), 2016-2018
  • Figure 80: Zoetis Breakdown of Net Sales, by Species, 2018
  • Figure 81: Zoetis Breakdown of Net Sales, by Business Segment, 2018
  • Figure 82: Vetoquinol S.A. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015-2017
  • Figure 83: Vetoquinol S.A. Breakdown of Net Sales, by Region, 2017
  • Figure 84: Virbac Revenue (US$ Mn) and Y-o-Y Growth (%), 2016-2018
  • Figure 85: Virbac R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016-2018
  • Figure 86: Virbac Breakdown of Net Sales, by Business Segment, 2018
  • Figure 87: Virbac Breakdown of Net Sales, by Region, 2018
目次
Product Code: TMRGL66551

The report provides revenue of the global equine supplement products market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global equine supplement products market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the equine supplement products market.

The report delves into the competitive landscape of the global equine supplement products market. Key players operating in the global equine supplement products market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global equine supplement products market profiled in this report.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Equine Supplement Products Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Equine Supplement Products Market Analysis and Forecast, 2017-2031
  • 4.5. Porter's Five Force Analysis

5. Market Outlook

  • 5.1. New Product Launch
  • 5.2. Key Mergers & Acquisitions
  • 5.3. Equine Population Overview, by Region
  • 5.4. Regulatory Scenario, by Region/globally

6. Global Equine Supplement Products Market Analysis and Forecast, by Supplement

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Supplement, 2017-2031
    • 6.3.1. Proteins/Amino Acids
    • 6.3.2. Vitamins
    • 6.3.3. Enzymes
    • 6.3.4. Electrolytes & Minerals
    • 6.3.5. Others
  • 6.4. Market Attractiveness Analysis, by Supplement

7. Global Equine Supplement Products Market Analysis and Forecasts, by Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Application, 2017-2031
    • 7.3.1. Performance Enhancement/Recovery
    • 7.3.2. Joint Disorder Prevention
    • 7.3.3. Others
  • 7.4. Market Attractiveness Analysis, by Application

8. Global Equine Supplement Products Market Analysis and Forecast, by Distribution Channel

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 8.3.1. Veterinary Hospital Pharmacies
    • 8.3.2. Retail Pharmacies
    • 8.3.3. Others
  • 8.4. Market Attractiveness Analysis, by Distribution Channel

9. Global Equine Supplement Products Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Equine Supplement Products Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Supplement, 2017-2031
    • 10.2.1. Proteins/Amino Acids
    • 10.2.2. Vitamins
    • 10.2.3. Enzymes
    • 10.2.4. Electrolytes & Minerals
    • 10.2.5. Others
  • 10.3. Market Value Forecast, by Application, 2017-2031
    • 10.3.1. Performance Enhancement/Recovery
    • 10.3.2. Joint Disorder Prevention
    • 10.3.3. Others
  • 10.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 10.4.1. Veterinary Hospital Pharmacies
    • 10.4.2. Retail Pharmacies
    • 10.4.3. Others
  • 10.5. Market Value Forecast, by Country, 2017-2031
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Supplement
    • 10.6.2. By Application
    • 10.6.3. By Distribution Channel
    • 10.6.4. By Country

11. Europe Equine Supplement Products Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Supplement, 2017-2031
    • 11.2.1. Proteins/Amino Acids
    • 11.2.2. Vitamins
    • 11.2.3. Enzymes
    • 11.2.4. Electrolytes & Minerals
    • 11.2.5. Others
  • 11.3. Market Value Forecast, by Application, 2017-2031
    • 11.3.1. Performance Enhancement/Recovery
    • 11.3.2. Joint Disorder Prevention
    • 11.3.3. Others
  • 11.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 11.4.1. Veterinary Hospital Pharmacies
    • 11.4.2. Retail Pharmacies
    • 11.4.3. Others
  • 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Spain
    • 11.5.5. Italy
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Supplement
    • 11.6.2. By Application
    • 11.6.3. By Distribution Channel
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Equine Supplement Products Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Supplement, 2017-2031
    • 12.2.1. Proteins/Amino Acids
    • 12.2.2. Vitamins
    • 12.2.3. Enzymes
    • 12.2.4. Electrolytes & Minerals
    • 12.2.5. Others
  • 12.3. Market Value Forecast, by Application, 2017-2031
    • 12.3.1. Performance Enhancement/Recovery
    • 12.3.2. Joint Disorder Prevention
    • 12.3.3. Others
  • 12.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 12.4.1. Veterinary Hospital Pharmacies
    • 12.4.2. Retail Pharmacies
    • 12.4.3. Others
  • 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Supplement
    • 12.6.2. By Application
    • 12.6.3. By Distribution Channel
    • 12.6.4. By Country/Sub-region

13. Latin America Equine Supplement Products Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Supplement, 2017-2031
    • 13.2.1. Proteins/Amino Acids
    • 13.2.2. Vitamins
    • 13.2.3. Enzymes
    • 13.2.4. Electrolytes & Minerals
    • 13.2.5. Others
  • 13.3. Market Value Forecast, by Application, 2017-2031
    • 13.3.1. Performance Enhancement/Recovery
    • 13.3.2. Joint Disorder Prevention
    • 13.3.3. Others
  • 13.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 13.4.1. Veterinary Hospital Pharmacies
    • 13.4.2. Retail Pharmacies
    • 13.4.3. Others
  • 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Supplement
    • 13.6.2. By Application
    • 13.6.3. By Distribution Channel
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Equine Supplement Products Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Supplement, 2017-2031
    • 14.2.1. Proteins/Amino Acids
    • 14.2.2. Vitamins
    • 14.2.3. Enzymes
    • 14.2.4. Electrolytes & Minerals
    • 14.2.5. Others
  • 14.3. Market Value Forecast, by Application, 2017-2031
    • 14.3.1. Performance Enhancement/Recovery
    • 14.3.2. Joint Disorder Prevention
    • 14.3.3. Others
  • 14.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 14.4.1. Veterinary Hospital Pharmacies
    • 14.4.2. Retail Pharmacies
    • 14.4.3. Others
  • 14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Supplement
    • 14.6.2. By Application
    • 14.6.3. By Distribution Channel
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (by tier and size of companies)
  • 15.2. Market Share Analysis, by Company, 2018
  • 15.3. Company Profiles
    • 15.3.1. Zoetis
      • 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. SWOT Analysis
      • 15.3.1.4. Strategic Overview
    • 15.3.2. Boehringer Ingelheim International GmbH
      • 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. SWOT Analysis
      • 15.3.2.4. Strategic Overview
    • 15.3.3. Bayer AG
      • 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. SWOT Analysis
      • 15.3.3.4. Strategic Overview
    • 15.3.4. Equine Products UK LTD
      • 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. SWOT Analysis
      • 15.3.4.4. Strategic Overview
    • 15.3.5. Purina Animal Nutrition LLC.
      • 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. SWOT Analysis
      • 15.3.5.4. Strategic Overview
    • 15.3.6. Vetoquinol S.A.
      • 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. SWOT Analysis
      • 15.3.6.4. Strategic Overview
    • 15.3.7. Kentucky Equine Research
      • 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. SWOT Analysis
      • 15.3.7.4. Strategic Overview
    • 15.3.8. Plusvital Limited
      • 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. SWOT Analysis
      • 15.3.8.4. Strategic Overview
    • 15.3.9. Lallemand Inc.
      • 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. SWOT Analysis
      • 15.3.9.4. Strategic Overview
    • 15.3.10. Virbac
      • 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.10.2. Product Portfolio
      • 15.3.10.3. SWOT Analysis
      • 15.3.10.4. Strategic Overview